Lawsuit Information Center

October 18, 2026

Tylenol Autism Lawsuit

Our lawyers stopped accepting new Tylenol autism and ADHD cases after Judge Denise Cote excluded the plaintiffs’ causation experts, a ruling that led to the dismissal of the federal lawsuits.

There is now real reason for renewed optimism. In July 2026, the Second Circuit overturned the judgments resulting from Judge Cote’s expert testimony rulings. The defendants then asked the appeals court to reconsider, and, as we discuss below, that request has now been denied.

But our firm has not yet resumed accepting new Tylenol autism or ADHD claims. The appeals court did not decide that Tylenol causes autism or ADHD, and important questions about the expert evidence still have to be addressed on remand. We will continue following the litigation and reassess our position as the next steps become clearer.

October 17, 2026

Social Media Addiction Lawsuit

by Ronald V. Miller, Jr.

This page is about social media addiction lawsuits and who is eligible to bring a claim. Our lawyers also provide the latest news on social media class action lawsuits (including the ongoing trial in California).

The problem that led to social media lawsuits is that millions of people, too many of whom are children, are addicted to social media platforms such as Facebook, Instagram, Snapchat, and others. For these vulnerable users, social media addiction can be very harmful and lead to things like eating disorders, depression, and, in some cases, suicide.

Now, these companies are facing a wave of new social media lawsuits alleging that they knowingly designed the algorithms of their platforms to lure young people into harmful addictions.

October 17, 2026

Olympus Scope Lawsuit

by Ronald V. Miller, Jr.

Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died from these medical scopes.

What happened? These awful infections were caused by dangerous, drug-resistant bacteria that were extremely difficult to treat.

So you had patients who went to the hospital, often getting diagnostic or therapeutic procedures that they did not think would be a big deal, only to come out with infections that damaged organs, required months of intensive care, or, tragically, proved fatal.

October 16, 2026

Dupixent Lawsuit for T-Cell Lymphoma

by Ronald V. Miller, Jr.

Dupixent lawsuits are now moving forward in federal court for patients who allege the drug caused, accelerated, or unmasked cutaneous T-cell lymphoma and related T-cell lymphomas.

On June 4, 2026, the Judicial Panel on Multidistrict Litigation centralized the federal Dupixent cases in MDL No. 3180, In re: Dupixent (Dupilumab) Products Liability Litigation, in the District of New Jersey before Judge Zahid N. Quraishi.

Dupixent, also known as dupilumab, is a biologic medication used to treat atopic dermatitis, asthma, COPD, and a host of other inflammatory conditions. For many patients, Dupixent has provided real relief where other treatments failed. But for some patients, the story has been very different and not one they could have expected.

October 16, 2026

Paraquat Lawsuit Settlement Amounts

by Ronald V. Miller, Jr.

Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit.

October 15, 2026

Uber Sexual Assault Lawsuits

by Ronald V. Miller, Jr.

Uber is defending thousands of sexual assault lawsuits brought by passengers who say they were sexually assaulted by Uber drivers. Plaintiffs are asking what Uber knew about the risk of sexual assault, how it screened drivers, what happened when complaints came in, and whether the company could have done more to keep dangerous drivers off the platform. In the $8.5 million verdict, jurors confirmed what we have been saying all along.

Federal cases have been consolidated in In re: Uber Technologies Inc., Passenger Sexual Assault Litigation, MDL No. 3084, in the Northern District of California. In an MDL, each survivor still has her own lawsuit and her own damages.

By October 2026, 4,916 cases were pending in the federal MDL, with additional claims proceeding in California state court. A federal bellwether case scheduled for October was settled before opening statements. We expect another trial to be scheduled soon.

October 15, 2026

Bard PowerPort Lawsuit

by Ronald V. Miller, Jr.

Bard PowerPort lawsuits allege that defects in implanted port catheters can cause fractures, migration, blood clots, infections, embolisms, and other serious complications. Thousands of product liability lawsuits are now pending against Bard and its parent company, Becton Dickinson, in a federal multidistrict litigation in Arizona. After a long slog, these cases are now moving forward.

The first bellwether trial ended with a partial defense verdict and a deadlocked jury on the central design defect claim. The most recent trial, Divelbliss v. C.R. Bard, led to a $40 million verdict. It involved an alleged fracture of a silicone Groshong catheter. Five bellwether trials are now expected to run through February 2027. So far, we are 1-1, with the third trial now getting underway. Our lawyers remain bullish on well-documented fracture, migration, and embolization cases.

This page provides the latest Bard PowerPort lawsuit updates, projected settlement amounts, and information about who may qualify to file a claim.

October 15, 2026

Baby Food Autism Lawsuit

by Ronald V. Miller, Jr.

Our law firm is handling baby food autism lawsuits in all 50 states.

Several popular brands of baby food contain high levels of heavy metals such as mercury, arsenic, lead, and cadmium. These heavy metals are well-known neurotoxins. Thousands of children may have developed autism and other neurodevelopmental disorders due to toxic metals found in baby foods.

A growing number of parents are pursuing a toxic baby food lawsuit to hold manufacturers accountable for their children’s exposure to harmful contaminants. These baby food autism lawsuits allege the manufacturers knew about heavy metals in their products, and children developed autism from consuming them.

October 13, 2026

Sex Abuse Lawsuit Settlement Amounts

by Ronald V. Miller, Jr.

If you are considering a sexual abuse lawsuit, you want to know what compensation may be available and what makes a claim worth pursuing. Our lawyers look at sex abuse settlement amounts and jury awards, analyzing both example compensation claims and discussing how payouts are calculated in sex abuse lawsuits. We also provide the latest news and updates in this ever-expanding litigation.

Our attorneys handle these claims nationwide. If you are a victim of sexual assault or abuse, call us today at 800-553-8082 or contact us confidentially online. Our sex abuse lawyers can help you pursue compensation and hold the responsible parties accountable.

Breast Mesh Lawsuits and Internal Bra Complications

by Ronald V. Miller, Jr.

Breast mesh lawsuits allege that some manufacturers promoted or allowed their mesh products to become widely used in breast reconstruction, augmentation, and revision procedures despite the fact that FDA has not cleared or approved any surgical mesh product for use in breast surgery. The FDA has specifically stated that the safety and effectiveness of surgical mesh in breast surgery, including augmentation and reconstruction, has not been determined.

These internal bra lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, AlloMax, FlexHD, Strattice, and DuroSorb marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those breast-specific applications had not been adequately studied or cleared by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, implant loss, breast deformity, and the need for additional surgery, many women had no reason to connect their injuries to the mesh product placed inside them.

Table of Contents